JP2024514010A5 - - Google Patents

Info

Publication number
JP2024514010A5
JP2024514010A5 JP2023563854A JP2023563854A JP2024514010A5 JP 2024514010 A5 JP2024514010 A5 JP 2024514010A5 JP 2023563854 A JP2023563854 A JP 2023563854A JP 2023563854 A JP2023563854 A JP 2023563854A JP 2024514010 A5 JP2024514010 A5 JP 2024514010A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
cycloalkyl
heterocyclyl
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023563854A
Other languages
English (en)
Japanese (ja)
Other versions
JP7642098B2 (ja
JP2024514010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025329 external-priority patent/WO2022225914A1/en
Publication of JP2024514010A publication Critical patent/JP2024514010A/ja
Publication of JP2024514010A5 publication Critical patent/JP2024514010A5/ja
Priority to JP2024217755A priority Critical patent/JP2025028177A/ja
Application granted granted Critical
Publication of JP7642098B2 publication Critical patent/JP7642098B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023563854A 2021-04-21 2022-04-19 カルボキシ-ベンズイミダゾールglp-1r調節化合物 Active JP7642098B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024217755A JP2025028177A (ja) 2021-04-21 2024-12-12 カルボキシ-ベンズイミダゾールglp-1r調節化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163177775P 2021-04-21 2021-04-21
US63/177,775 2021-04-21
US202163285410P 2021-12-02 2021-12-02
US63/285,410 2021-12-02
PCT/US2022/025329 WO2022225914A1 (en) 2021-04-21 2022-04-19 Carboxy-benzimidazole glp-1r modulating compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024217755A Division JP2025028177A (ja) 2021-04-21 2024-12-12 カルボキシ-ベンズイミダゾールglp-1r調節化合物

Publications (3)

Publication Number Publication Date
JP2024514010A JP2024514010A (ja) 2024-03-27
JP2024514010A5 true JP2024514010A5 (cg-RX-API-DMAC10.html) 2024-04-24
JP7642098B2 JP7642098B2 (ja) 2025-03-07

Family

ID=81654849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023563854A Active JP7642098B2 (ja) 2021-04-21 2022-04-19 カルボキシ-ベンズイミダゾールglp-1r調節化合物
JP2024217755A Pending JP2025028177A (ja) 2021-04-21 2024-12-12 カルボキシ-ベンズイミダゾールglp-1r調節化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024217755A Pending JP2025028177A (ja) 2021-04-21 2024-12-12 カルボキシ-ベンズイミダゾールglp-1r調節化合物

Country Status (27)

Country Link
US (2) US20230021705A1 (cg-RX-API-DMAC10.html)
EP (2) EP4271674B9 (cg-RX-API-DMAC10.html)
JP (2) JP7642098B2 (cg-RX-API-DMAC10.html)
KR (2) KR20260104194A (cg-RX-API-DMAC10.html)
AU (2) AU2022260487B2 (cg-RX-API-DMAC10.html)
BR (1) BR112023021978A2 (cg-RX-API-DMAC10.html)
CA (1) CA3216372A1 (cg-RX-API-DMAC10.html)
CL (1) CL2023003113A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023013766A2 (cg-RX-API-DMAC10.html)
CR (1) CR20230493A (cg-RX-API-DMAC10.html)
DK (1) DK4271674T6 (cg-RX-API-DMAC10.html)
DO (2) DOP2023000231A (cg-RX-API-DMAC10.html)
ES (1) ES3025032T7 (cg-RX-API-DMAC10.html)
FI (1) FI4271674T6 (cg-RX-API-DMAC10.html)
HR (1) HRP20250415T4 (cg-RX-API-DMAC10.html)
HU (1) HUE071198T2 (cg-RX-API-DMAC10.html)
IL (1) IL307768A (cg-RX-API-DMAC10.html)
LT (1) LT4271674T (cg-RX-API-DMAC10.html)
MX (1) MX2023012419A (cg-RX-API-DMAC10.html)
PE (1) PE20232051A1 (cg-RX-API-DMAC10.html)
PH (1) PH12023552861A1 (cg-RX-API-DMAC10.html)
PL (1) PL4271674T6 (cg-RX-API-DMAC10.html)
PT (1) PT4271674T (cg-RX-API-DMAC10.html)
SI (1) SI4271674T2 (cg-RX-API-DMAC10.html)
TW (2) TW202402752A (cg-RX-API-DMAC10.html)
UA (1) UA130357C2 (cg-RX-API-DMAC10.html)
WO (1) WO2022225914A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20220178A (es) 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r
SI4097097T1 (sl) 2020-01-29 2025-04-30 Gilead Sciences, Inc. Spojine, ki modulirajo glp-1r
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
EP4304711A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
US12180197B2 (en) 2021-03-11 2024-12-31 Gilead Sciences, Inc. GLP-1R modulating compounds
LT4271672T (lt) 2021-04-21 2026-03-10 Gilead Sciences, Inc. Karboksibenzimidazolo junginiai, moduliuojantys glp-1r
CN117098758A (zh) * 2021-06-24 2023-11-21 杭州中美华东制药有限公司 Glp-1受体激动剂及其组合物和用途
US20250066338A1 (en) 2021-12-16 2025-02-27 Astrazeneca Ab Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
US20250042882A1 (en) 2021-12-16 2025-02-06 Astrazeneca Ab Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
CN119907794A (zh) 2022-09-22 2025-04-29 盐野义制药株式会社 具有glp-1受体激动剂作用的稠环化合物
WO2024102625A1 (en) 2022-11-11 2024-05-16 Eli Lilly And Company Glucagon-like peptide 1 receptor agonists
CR20250178A (es) 2022-11-16 2025-06-06 Lilly Co Eli Agonistas del receptor del péptido-1 similar al glucagón
CN118496200A (zh) * 2023-02-14 2024-08-16 成都康弘药业集团股份有限公司 吲唑啉酮类化合物及其制备方法和用途
EP4731245A1 (en) * 2023-06-23 2026-04-29 Merck Sharp & Dohme LLC Use of a long-acting oxyntomodulin derivative for treament of fatty liver disease
EP4777197A2 (en) 2023-09-14 2026-07-22 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
WO2025109387A1 (en) 2023-11-24 2025-05-30 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
TW202600132A (zh) 2024-03-08 2026-01-01 美商安尼波那生物公司 用於治療肥胖症及提高減重之方法
TW202608914A (zh) * 2024-04-23 2026-03-01 美商領導醫療公司 用於肥胖症及t2dm之人類glp1r及gipr之單促效劑及雙重促效劑化合物
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
CR20220178A (es) * 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r
KR102841983B1 (ko) * 2019-11-04 2025-08-04 주식회사 엘지화학 광변조 디바이스의 제조 방법
EP4069686B1 (en) * 2019-12-02 2025-01-22 Hyundai Pharm Co., Ltd. Glp-1 receptor agonist
CN116348464B (zh) * 2020-10-12 2026-06-16 杭州中美华东制药有限公司 苯并咪唑酮类glp-1受体激动剂及其用途

Similar Documents

Publication Publication Date Title
JP2024514009A5 (cg-RX-API-DMAC10.html)
HRP20250415T1 (hr) Modulirajući spojevi karboksi-benzimidazola glp-1r
CN115335374B (zh) Glp-1r调节化合物
US10941113B2 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
JP2023513272A5 (cg-RX-API-DMAC10.html)
ES2713566T3 (es) Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
JP2023540609A5 (cg-RX-API-DMAC10.html)
CN1195526C (zh) 含对映体纯β-D-二氧戊环核苷的药物产品
JP6434416B2 (ja) PDE4阻害剤とPI3δ阻害剤または二重PI3δ−γキナーゼ阻害剤とを含有する薬学的組成物
JP2023515404A5 (cg-RX-API-DMAC10.html)
JP2019069940A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
US6525033B1 (en) Nucleosides with anti-hepatitis B virus activity
JP2021095409A (ja) 心臓保護及び腎臓保護の抗糖尿病治療におけるリナグリプチンの使用
JP7769695B2 (ja) Glp-1rアゴニストの結晶形態およびその使用
WO2018043747A1 (ja) 抗b型肝炎ウイルス剤
KR20240068737A (ko) Glp-1r 효능제로서의 벤즈이미다졸 카복실산
US20160115149A1 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
JP2019517478A5 (cg-RX-API-DMAC10.html)
JPWO2010027005A1 (ja) 置換アミン誘導体及びこれを有効成分とする医薬組成物
JP2009102334A (ja) 神経変性疾患治療剤
CN121985948A (zh) Glp-1r激动剂的制剂及其制备方法
WO2011127388A2 (en) Inverse agonists and neutral antagonists for the tsh receptor
RU2470927C2 (ru) Производные с азотсодержащим шестичленным ароматическим кольцом и содержащие их фармацевтические продукты
TW201522291A (zh) 胍基苯甲酸酯化合物
US6245817B1 (en) NPY5 receptor antagonists and methods for using same